Published in Lancet Oncol on March 01, 2003
Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology (2011) 2.01
Current management of gallbladder carcinoma. Oncologist (2010) 1.83
Genomic spectra of biliary tract cancer. Nat Genet (2015) 1.58
Laparoscopic surgery for cancer: a systematic review and a way forward. J Am Coll Surg (2010) 1.58
Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer (2007) 1.28
Prognostic significance of race and tumor size in carcinosarcoma of gallbladder: a meta-analysis of 68 cases. Int J Clin Exp Pathol (2008) 1.16
Incidental carcinoma gall bladder during laparoscopic cholecystectomy for symptomatic gall stone disease. Surg Endosc (2008) 1.14
Gallstone disease after extended (D2) lymph node dissection for gastric cancer. World J Surg (2005) 1.10
Management strategies for gallbladder polyps: is it possible to predict malignant gallbladder polyps? Gut Liver (2008) 1.06
Gallbladder Cancer in the 21st Century. J Oncol (2015) 1.02
Gallbladder cancer in the twentieth century: single institution's experience. World J Surg (2003) 1.00
Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma. Surg Endosc (2007) 1.00
miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer. Int J Clin Exp Pathol (2014) 0.98
Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene. Int J Clin Oncol (2008) 0.96
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int (2015) 0.96
Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. World J Gastroenterol (2005) 0.95
Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice. Proc Natl Acad Sci U S A (2010) 0.95
Incidentally detected gallbladder cancer- the controversies and algorithmic approach to management. Indian J Surg (2012) 0.95
Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer. Cancer Sci (2014) 0.95
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma. Diagn Pathol (2012) 0.95
Does PET-CT scan have a role prior to radical re-resection for incidental gallbladder cancer? HPB (Oxford) (2008) 0.94
Gallbladder cancer: the basics. Gastroenterol Hepatol (N Y) (2008) 0.92
Diagnosis of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg (2008) 0.92
A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One (2014) 0.92
Systematic review: should routine resection of the extra-hepatic bile duct be performed in gallbladder cancer? Saudi J Gastroenterol (2010) 0.92
Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours. J Clin Pathol (2006) 0.92
Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma. Nucl Med Mol Imaging (2012) 0.90
DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clin Epigenetics (2012) 0.87
Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol (2008) 0.87
Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma. Surg Today (2012) 0.86
Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One (2012) 0.86
The impact of routine histopathological examination on cholecystectomy specimens from an Asian demographic. Ann R Coll Surg Engl (2012) 0.86
Perimuscular connective tissue contains more and larger lymphatic vessels than the shallower layers in human gallbladders. World J Gastroenterol (2007) 0.86
Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics. Biochem Biophys Res Commun (2014) 0.85
Rare presentation of malignant porcelain gallbladder with intrahepatic ductal calcification and surgical obstructive jaundice. Indian J Surg Oncol (2011) 0.84
Postoperative chemoradiotherapy for gallbladder cancer. Strahlenther Onkol (2012) 0.83
Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases (2015) 0.83
Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma. World J Gastroenterol (2005) 0.83
Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis. Gastroenterol Res Pract (2011) 0.83
Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma. Int J Clin Oncol (2010) 0.83
Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies. Nutrients (2015) 0.83
Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. J Cancer Res Clin Oncol (2008) 0.82
LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma. PLoS One (2012) 0.82
Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine. Int J Clin Exp Pathol (2014) 0.81
The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer. BMC Cancer (2014) 0.81
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers. Invest New Drugs (2005) 0.80
Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. World J Gastroenterol (2010) 0.80
Expression of MUC1 and MUC4 in gallbladder adenocarcinoma. Korean J Pathol (2012) 0.79
Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population. J Cancer Res Clin Oncol (2014) 0.79
Gallbladder cancer: Clinical and pathological approach. World J Clin Cases (2014) 0.79
Flowcharts for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg (2008) 0.79
Imaging of malignancies of the biliary tract- an update. Cancer Imaging (2014) 0.79
Conformal radiotherapy for squamous cell carcinoma of gallbladder: a case report. Case Rep Med (2010) 0.79
Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol (2015) 0.79
Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention. Surg Endosc (2015) 0.79
Squamous-cell and non-squamous-cell carcinomas of the gallbladder have different risk factors. Lancet Oncol (2003) 0.78
Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease? Biomed Res Int (2014) 0.78
Evaluation of surgical treatment for incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy: single center results. BMC Res Notes (2017) 0.78
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer. BMC Cancer (2015) 0.78
A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks. J Gastroenterol (2015) 0.78
Gallbladder selection for histopathological analysis based on a simple method: a prospective comparative study. Ann R Coll Surg Engl (2012) 0.78
The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma. BMC Cancer (2007) 0.78
Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies. J Gastrointest Oncol (2014) 0.78
Expression of angiostatin cDNA in human gallbladder carcinoma cell line GBC-SD and its effect on endothelial proliferation and growth. World J Gastroenterol (2006) 0.78
Prognosis of incidental gallbladder carcinoma is not influenced by the primary access technique: analysis of 837 incidental gallbladder carcinomas in the German Registry. Surg Endosc (2013) 0.77
Two distinct pathways of p16 gene inactivation in gallbladder cancer. World J Gastroenterol (2007) 0.77
Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases. World J Gastroenterol (2015) 0.77
Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection. Korean J Hepatobiliary Pancreat Surg (2012) 0.77
Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report. Cureus (2016) 0.77
Down-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescence. World J Gastroenterol (2014) 0.77
Clinicopathological features of gallbladder papillary adenocarcinoma. Medicine (Baltimore) (2014) 0.77
Expression of heat-shock protein gp96 in gallbladder cancer and its prognostic clinical significance. Int J Clin Exp Pathol (2015) 0.76
Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma. World J Gastroenterol (2004) 0.76
A clinicopathological analysis in unsuspected gallbladder carcinoma: a report of 23 cases. World J Gastroenterol (2007) 0.76
Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile. Future Oncol (2014) 0.76
Surgical approach does not influence the outcome of incidental gallbladder carcinoma. Int J Clin Exp Med (2015) 0.76
A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer. Gut Liver (2013) 0.76
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. Int J Mol Sci (2016) 0.76
TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway. BMC Cancer (2016) 0.75
Cytopathological diagnosis of gallbladder mass and mural thickening based on imaging findings: A prospective study of 51 cases. J Cytol (2016) 0.75
KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9. Int J Clin Exp Pathol (2013) 0.75
Clinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma. Oncol Lett (2016) 0.75
Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies. Med Sci Monit Basic Res (2016) 0.75
Parity and risk of death from gallbladder cancer among a cohort of premenopausal parous women in Taiwan. Int J Environ Res Public Health (2015) 0.75
Over-expression of beclin-1 in gallbladder carcinoma and its relationship with prognosis. Contemp Oncol (Pozn) (2014) 0.75
Pachymic acid inhibits tumorigenesis in gallbladder carcinoma cells. Int J Clin Exp Med (2015) 0.75
Metastatic gallbladder adenocarcinoma with signet-ring cells: A case report. J Med Case Rep (2011) 0.75
IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation. Oncol Lett (2016) 0.75
Incidental gallbladder cancer after cholecystectomy: 1990 to 2014. Onco Targets Ther (2016) 0.75
A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature. Onco Targets Ther (2016) 0.75
Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer. Korean J Hepatobiliary Pancreat Surg (2012) 0.75
Six year disease free survival after liver transplantation in a patient with T3 gallbladder carcinoma: case presentation and review of the literature. World J Surg Oncol (2006) 0.75
Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage. PLoS One (2016) 0.75
Expression of CCK Receptors in Carcinoma Gallbladder and Cholelithiasis: A Pilot Study. J Clin Diagn Res (2015) 0.75
A unique case of two primaries: carcinoma breast with carcinoma gallbladder. BMJ Case Rep (2013) 0.75
Gallbladder cancer revealed by an endobiliary tumor thrombus. Indian J Surg (2012) 0.75
Validation of revised American Joint Committee on Cancer staging for gallbladder cancer based on a single institution experience. Am Surg (2013) 0.75
Gallbladder Adenosquamous Carcinoma Associated with Biliopancreatic Maljunction and Cystic Metastases of the Liver Miming Abscess. Indian J Surg (2013) 0.75
Cytologic diagnosis of gallbladder lesions - A study of 150 cases. Indian J Surg (2010) 0.75
Carcinoma Gallbladder- an Indian Problem. Indian J Surg Oncol (2016) 0.75
Penile carcinoma: a challenge for the developing world. Lancet Oncol (2004) 1.95
Management of gingivobuccal complex cancer. Ann R Coll Surg Engl (2008) 1.11
Gallbladder cancer. Curr Treat Options Gastroenterol (2006) 1.02
Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor. Breast Cancer Res Treat (2010) 0.84
Retroperitoneal sarcomas- a challenging problem. Indian J Surg Oncol (2012) 0.83
Clinicopathological study of bronchogenic carcinoma. Respirology (2004) 0.82
ELISA in the evaluation of therapeutic response to albendazole in neurocysticercosis. J Infect (2007) 0.79
Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System. Am J Surg Pathol (2017) 0.77